ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
265 hedge funds and large institutions have $4.57B invested in Intra-Cellular Therapies Inc. in 2022 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 93 increasing their positions, 90 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% less capital invested
Capital invested by funds: $4.88B → $4.57B (-$307M)
15% less funds holding in top 10
Funds holding in top 10: 13 → 11 (-2)
Holders
265
Holding in Top 10
11
Calls
$33.5M
Puts
$24.9M
Top Buyers
| 1 | +$115M | |
| 2 | +$51.6M | |
| 3 | +$44.3M | |
| 4 |
BlackRock
New York
|
+$33M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$23M |
Top Sellers
| 1 | -$154M | |
| 2 | -$119M | |
| 3 | -$35.5M | |
| 4 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
-$30.7M |
| 5 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$21.2M |